Treatment group | IL-1β | IL-6 | IL-10 | CCL2 | CXCL1 |
---|---|---|---|---|---|
sham + veh (n = 7) | 4.9 ± 1.3 | 16.1 ± 10.8 | 1.3 ± 2.0 | 53.0 ± 7.6 | 103.8 ± 100.2 |
CHI + veh (n = 20) | 9.8 ± 4.7 | 41.0 ± 39.1 | 7.2 ± 5.8 | 445.1 ± 240.4 | 274.0 ± 211.2 |
CHI + MW151 at 3 h and 6 h (n = 10) | 7.0 ± 3.8 | 22.0 ± 13.7 | 6.5 ± 3.0 | 403.3 ± 134.5 | 235.6 ± 125.9 |
CHI + MW151 at 3 h (n = 10) | 6.8 ± 2.5 | 21.4 ± 15.4 | 5.6 ± 4.6 | 393.5 ± 134.6 | 214.6 ± 132.1 |
CHI + MW151 at 6 h (n = 9) | 6.8 ± 2.5 | 23.7 ± 21.7 | 6.9 ± 4.3 | 414.2 ± 134.5 | 246.9 ± 88.3 |